Olin Bioscience (688319.SH) resubmits application for H-share issuance and listing to the Hong Kong Stock Exchange and publishes application materials.

Zhito Finance and Economics APP News, Eurin Biotech (688319.SH) announced that the company is applying for the overseas issuance of shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. According to the schedule for this issuance and listing, the company resubmitted the application for issuance and listing to the Hong Kong Stock Exchange on June 30, 2026, and published the application materials on the website of the Hong Kong Stock Exchange on the same day. The application materials were prepared and published by the company in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, and are draft versions, with the information contained therein subject to timely updates and revisions.